HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 285/2/F319    most recent 00432.2002v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (25) Citing Articles via Google Scholar Google Scholar Articles by Yokota, N. Articles by Rabb, H. Search for Related Content PubMed PubMed Citation Articles by Yokota, N. Articles by Rabb, H.

Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury

¹Division of Nephrology, ²Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Submitted 19 December 2002 ; accepted in final form 20 April 2003

Recent data support a modulatory role for CD4 T cells in experimental renal ischemia-reperfusion injury (IRI). CD4 T cells can functionally differentiate to either a Th1 (IFN- producing) or the counterbalancing Th2 (IL-4) phenotype. The enzymes signal transducers and activators of transcription (STAT) 4 and STAT6 regulate Th1 or Th2 differentiation and cytokine production, respectively. We therefore hypothesized that mice that were STAT4 deficient would be protected from renal IRI and that STAT6-deficient mice would have a more severe course. Intracellular cytokine staining of splenocytes from STAT4–/– or STAT6–/– exhibited distinct IFN- and IL-4 cytokine expression profiles. STAT6–/– had markedly worse renal function and tubular injury postischemia compared with wild type. STAT4–/– had only mildly improved function. Renal phagocyte infiltration and ICAM-1 upregulation were similar in STAT4–/–, STAT6–/–, and wild type. To evaluate if the mechanism of the marked worsening in the STAT6–/– mice could be due to IL-4 deficiency, IL-4-deficient mice were studied and had similar postischemic phenotype to STAT6–/– mice. These data demonstrate that the STAT6 pathway has a major protective role in renal IRI. IL-4 deficiency is a likely mechanism underlying the STAT6 effect. A "yin-yang" role for inflammation is emerging in renal IRI, similar to recent observations in atherosclerosis.

Th1/Th2 cells; inflammation; interleukin-4

This article has been cited by other articles:

				T. Weimbs Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1 Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1423 - F1432. [Abstract] [Full Text] [PDF]

				P. Devarajan Update on Mechanisms of Ischemic Acute Kidney Injury J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1503 - 1520. [Full Text] [PDF]

				P. Fiorina, M. J. Ansari, M. Jurewicz, M. Barry, V. Ricchiuti, R. N. Smith, S. Shea, T. K. Means, H. Auchincloss Jr., A. D. Luster, et al. Role of CXC Chemokine Receptor 3 Pathway in Renal Ischemic Injury J. Am. Soc. Nephrol., March 1, 2006; 17(3): 716 - 723. [Abstract] [Full Text] [PDF]

				H. Rabb Immune Modulation of Acute Kidney Injury J. Am. Soc. Nephrol., March 1, 2006; 17(3): 604 - 606. [Full Text] [PDF]

				H. Rabb Paracrine and differentiation mechanisms underlying stem cell therapy for the damaged kidney Am J Physiol Renal Physiol, July 1, 2005; 289(1): F29 - F30. [Full Text] [PDF]

				F. Togel, Z. Hu, K. Weiss, J. Isaac, C. Lange, and C. Westenfelder Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms Am J Physiol Renal Physiol, July 1, 2005; 289(1): F31 - F42. [Abstract] [Full Text] [PDF]

				J. Mishra, K. Mori, Q. Ma, C. Kelly, J. Yang, M. Mitsnefes, J. Barasch, and P. Devarajan Amelioration of Ischemic Acute Renal Injury by Neutrophil Gelatinase-Associated Lipocalin J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3073 - 3082. [Abstract] [Full Text] [PDF]